Market Overview:
The global encephalitis vaccination market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of encephalitis, increasing awareness about encephalitis and its prevention, and technological advancements in the field of vaccine development. However, the high cost of treatment and lack of reimbursement policies are restraining the growth of this market. The global encephalitis vaccination market is segmented on the basis of type, application, and region. On the basis of type, it is divided into three segments: encephalitis b vaccine, encephalitis attenuated live vaccine (EALV), and other vaccines (including Japanese B Encephalitis [JE] vaccine). The EALV segment is expected to grow at a higher CAGR during the forecast period owing to its advantages over other types such as safety profile and long-term efficacy data. On the basis of application, it is classified into two segments: hospitals and other medical institutions. Hospitals are expected to account for a larger share in terms revenue due to increased adoption rates for preventive measures among patients admitted in these institutes across regions worldwide.
Product Definition:
Encephalitis vaccination is a vaccine administered to prevent encephalitis, a condition which results in inflammation of the brain. The vaccine is typically given as part of the routine childhood immunization schedule in the United States. Encephalitis vaccination is also recommended for adults who are at risk for contracting the disease, such as those who work with animals or travel to areas where encephalitis is common.
encephalitis b vaccine:
The global encephalitis b vaccine, it's usage and growth factor in the Encephalitis market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of viral infections such as measles, chickenpox, mumps, rubella & hepatitis among others are anticipated to boost demand for vaccines globally which is further expected to fuel growth over the forecast period.
encephalitis attenuated live vaccine:
Encephalitis attenuated live vaccine is a new and innovative way of preventing encephalitis. It's a safe and effective way to prevent the disease, which has led to increasing demand in the market. The vaccine consists of weakened form of virus that does not cause disease but helps antibodies to your body fight against viruses, thus protecting you from encephalitis.
Application Insights:
Based on the application, the global encephalitis vaccination market is segmented into hospitals and other medical institutions. Hospitals held the largest share of over 70.0% in 2017 owing to factors such as a high incidence rate of hospital-acquired infections and favorable reimbursement policies for treating patients with vaccine-preventable diseases. Vaccination against encephalitis at hospitals helps reduce healthcare costs by decreasing patient admissions and duration of stay (DoS). Furthermore, it also helps in controlling outbreaks by immunizing a large number of people at once.
The other medical institutes segment is expected to witness lucrative growth during forecast years due to increasing awareness about Encephalitis among general practitioners (GPs) across countries such as India, China Japan etc., which has resulted in increased demand for these vaccines from GPs clinics across regions including Middle East & Africa and Asia Pacific region.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers coupled with high awareness levels is responsible for its continued dominance over the forecast period. In addition, increasing demand for technologically advanced medical products is expected to drive regional growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the next eight years owing to rising incidence rates of this disease coupled with growing target population base in countries such as India and China. Furthermore, government initiatives aimed at increasing immunization activities are likely to support regional growth during the estimated time span.
The Latin American market was valued at USD X million in 2017.
Growth Factors:
- Increasing incidence of encephalitis across the globe
- Growing awareness about encephalitis and its prevention among people
- Government initiatives and programs to promote vaccination against encephalitis
- Availability of funds for research and development activities in the field of encephalitis vaccine technology
- Rising demand for safe and effective vaccines against various forms of encephalitis
Scope Of The Report
Report Attributes
Report Details
Report Title
Encephalitis Vaccination Market Research Report
By Type
encephalitis b vaccine, encephalitis attenuated live vaccine, Encephalitis Vaccinatio
By Application
Hospitals, Other medical institutions
By Companies
Novartis, Sanofi, Chengdu institute of biologica, Wuhan Institute of Biological, Lanzhou Institute of Biological, Beijing Taitan, Valneva, Bharat Biotech, Liaoning Chengda, Encephalitis Vaccinatio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Encephalitis Vaccination Market Report Segments:
The global Encephalitis Vaccination market is segmented on the basis of:
Types
encephalitis b vaccine, encephalitis attenuated live vaccine, Encephalitis Vaccinatio
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Other medical institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Sanofi
- Chengdu institute of biologica
- Wuhan Institute of Biological
- Lanzhou Institute of Biological
- Beijing Taitan
- Valneva
- Bharat Biotech
- Liaoning Chengda
- Encephalitis Vaccinatio
Highlights of The Encephalitis Vaccination Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- encephalitis b vaccine
- encephalitis attenuated live vaccine
- Encephalitis Vaccinatio
- By Application:
- Hospitals
- Other medical institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Encephalitis Vaccination Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Encephalitis is a serious brain infection caused by a virus. It can be deadly in young children and adults, and it can cause permanent damage to the brain. Encephalitis vaccination is a preventative measure that helps protect people from this disease.
Some of the major companies in the encephalitis vaccination market are Novartis, Sanofi, Chengdu institute of biologica, Wuhan Institute of Biological, Lanzhou Institute of Biological, Beijing Taitan, Valneva, Bharat Biotech, Liaoning Chengda, Encephalitis Vaccinatio.
The encephalitis vaccination market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Encephalitis Vaccination Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Encephalitis Vaccination Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Encephalitis Vaccination Market - Supply Chain
4.5. Global Encephalitis Vaccination Market Forecast
4.5.1. Encephalitis Vaccination Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Encephalitis Vaccination Market Size (000 Units) and Y-o-Y Growth
4.5.3. Encephalitis Vaccination Market Absolute $ Opportunity
5. Global Encephalitis Vaccination Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Encephalitis Vaccination Market Size and Volume Forecast by Type
5.3.1. encephalitis b vaccine
5.3.2. encephalitis attenuated live vaccine
5.3.3. Encephalitis Vaccinatio
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Encephalitis Vaccination Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Encephalitis Vaccination Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Other medical institutions
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Encephalitis Vaccination Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Encephalitis Vaccination Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Encephalitis Vaccination Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Encephalitis Vaccination Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Encephalitis Vaccination Demand Share Forecast, 2019-2026
9. North America Encephalitis Vaccination Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Encephalitis Vaccination Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Encephalitis Vaccination Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Other medical institutions
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Encephalitis Vaccination Market Size and Volume Forecast by Type
9.7.1. encephalitis b vaccine
9.7.2. encephalitis attenuated live vaccine
9.7.3. Encephalitis Vaccinatio
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Encephalitis Vaccination Demand Share Forecast, 2019-2026
10. Latin America Encephalitis Vaccination Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Encephalitis Vaccination Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Encephalitis Vaccination Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Other medical institutions
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Encephalitis Vaccination Market Size and Volume Forecast by Type
10.7.1. encephalitis b vaccine
10.7.2. encephalitis attenuated live vaccine
10.7.3. Encephalitis Vaccinatio
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Encephalitis Vaccination Demand Share Forecast, 2019-2026
11. Europe Encephalitis Vaccination Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Encephalitis Vaccination Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Encephalitis Vaccination Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Other medical institutions
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Encephalitis Vaccination Market Size and Volume Forecast by Type
11.7.1. encephalitis b vaccine
11.7.2. encephalitis attenuated live vaccine
11.7.3. Encephalitis Vaccinatio
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Encephalitis Vaccination Demand Share, 2019-2026
12. Asia Pacific Encephalitis Vaccination Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Encephalitis Vaccination Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Encephalitis Vaccination Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Other medical institutions
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Encephalitis Vaccination Market Size and Volume Forecast by Type
12.7.1. encephalitis b vaccine
12.7.2. encephalitis attenuated live vaccine
12.7.3. Encephalitis Vaccinatio
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Encephalitis Vaccination Demand Share, 2019-2026
13. Middle East & Africa Encephalitis Vaccination Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Encephalitis Vaccination Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Encephalitis Vaccination Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Other medical institutions
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Encephalitis Vaccination Market Size and Volume Forecast by Type
13.7.1. encephalitis b vaccine
13.7.2. encephalitis attenuated live vaccine
13.7.3. Encephalitis Vaccinatio
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Encephalitis Vaccination Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Encephalitis Vaccination Market: Market Share Analysis
14.2. Encephalitis Vaccination Distributors and Customers
14.3. Encephalitis Vaccination Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novartis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Chengdu institute of biologica
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Wuhan Institute of Biological
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lanzhou Institute of Biological
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beijing Taitan
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Valneva
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bharat Biotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Liaoning Chengda
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Encephalitis Vaccinatio
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
